Antibiotic Prophylaxis for Dacryocystorhinostomy
For routine dacryocystorhinostomy (DCR) without active infection, a single perioperative dose of intravenous cefazolin 2 g is sufficient and preferred over extended oral antibiotic courses. 1, 2
Recommended Antibiotic Regimen
Standard Protocol (No Active Infection)
Administer cefazolin 2 g IV as a single dose 30–60 minutes before skin incision for external DCR or at the start of endoscopic DCR. 1, 2
No postoperative systemic antibiotics are required when there is no preoperative infection; topical antibiotic eye drops (such as dexamethasone/neomycin/polymyxin combination) three times daily for one week postoperatively provide adequate local coverage. 3
Re-dose cefazolin 1 g IV intraoperatively if the procedure exceeds 2 hours, as recommended for lacrimal duct wound procedures. 1
β-Lactam Allergy Alternative
- For documented β-lactam allergy, use vancomycin 30 mg/kg IV infused over 120 minutes, with the infusion completed at least 30 minutes before incision. 1
When to Modify the Standard Protocol
Active or Recent Dacryocystitis
Patients with acute dacryocystitis within two weeks of surgery require extended antibiotic therapy: start oral amoxicillin/clavulanate or cephalexin 3–7 days preoperatively and continue for one week postoperatively. 4, 5
If purulent material is encountered intraoperatively, administer intravenous cefazolin 2 g during surgery even if not given preoperatively. 4
Patients with mucopurulence at surgery have a 6-fold increased risk of postoperative infection (OR 6.24, p < 0.05) and warrant consideration of extended oral antibiotics postoperatively. 6
Preoperative Inflammatory Signs
Visible medial canthal inflammation or mucocele/mucopyocele mandates perioperative oral antibiotics: amoxicillin/clavulanate or cephalexin starting 3–7 days before surgery and continuing one week after. 4, 5
History of recurrent acute dacryocystitis episodes is associated with higher positive lacrimal sac cultures (most commonly Staphylococcus aureus) and justifies selective antibiotic use. 5
Evidence Supporting Single-Dose Prophylaxis
A randomized trial of 338 patients demonstrated that single-dose IV cefazolin 1 g was non-inferior to 5 days of oral cephalexin 500 mg twice daily, with zero infections in the IV group versus one infection (0.6%) in the oral group. 2
Retrospective data from 82 external DCR cases without systemic antibiotics showed only 1.2% infection rate (95% CI 0.03–6.6%), suggesting the number needed to treat with prophylaxis to prevent one infection would be 104. 3
Multi-institutional data from 331 endoscopic DCR cases found no significant difference in infection rates (6.6% overall) between various permutations of peri- and postoperative antibiotics in patients without active preoperative dacryocystitis. 7
A series of 697 external DCR cases found no association between intraoperative antibiotic use and lower postoperative complication rates in patients without preoperative inflammatory signs. 5
Endoscopic DCR Considerations
Concurrent endoscopic sinus surgery (ESS) performed to address comorbid rhinosinusitis significantly reduces postoperative infection risk (OR 0.17, p < 0.05) and does not require modification of the standard single-dose prophylaxis protocol. 6
Postoperative infection after endoscopic DCR with standard prophylaxis (single IV dose plus 10-day oral course) occurs in only 2.6% of cases, most commonly acute rhinosinusitis (66.7% of infections). 6
Common Pitfalls to Avoid
Do not routinely prescribe extended oral antibiotic courses for uncomplicated DCR; this increases antimicrobial resistance without reducing infection rates. 7, 3
Do not withhold antibiotics in patients with recent acute dacryocystitis (within two weeks); these patients had significantly higher infection rates when peri- or postoperative antibiotics were omitted (p = 0.008). 7
Do not substitute oral antibiotics for the preoperative IV dose; tissue concentrations at the time of incision are inadequate with oral administration alone. 2
Do not administer antibiotics after the surgical incision has been made; prophylaxis must be given before incision to be effective. 1
Target Organisms
Primary pathogens in lacrimal sac infections are Staphylococcus aureus, followed by other staphylococci and streptococci; cefazolin provides appropriate coverage for these organisms. 5
Positive lacrimal sac cultures occur in only 8.3% of cases overall, but are significantly more common in patients with prior mucocele, mucopyocele, or acute dacryocystitis. 5
Duration and Timing Summary
Prophylaxis is limited to the operative period with a maximum of 24 hours; extending beyond this provides no benefit and promotes resistance. 1
The presence of surgical drains does not justify prolonging antibiotic prophylaxis beyond the operative period. 1
For external DCR, the single IV dose should be administered 30–60 minutes before skin incision; for endoscopic DCR, at the start of the procedure. 1, 2